Google

YouTube

Spotify

Scientific Sense Podcast

Tuesday, March 13, 2018

Lies spread faster than truth

A recent study (1) that shows lies spread ten times faster than truth and reach as many more believers, is troubling. This appears to go against the basic notions of homo-sapien evolution as one would assume selection advantages to those who could separate truth from lies. So, either such advantages did not exist or the structure of recent society has given undefinable advantages to those who go against the grain. If it is the former, that implies who lived longer was able to utilize lies more advantageously and if it is the latter, perhaps society can do something about it.
As the social media kings rise - doling out information with zero marginal cost, they do not seem to understand that their actions have societal costs. As economists stick to their century old text books that discuss the trade-off between work and leisure, they are missing an important point. Leisure has a dark side, especially in the presence of "social media," where those with low cost of lack of work could derive higher utility from unbelievable lies than boring truth. The US currently has a leader who seems to have figured out this idea, perhaps by sheer accident. As the academics in ivy towers try to set the story right, they do not seem to realize that they have been rendered irrelevant by a populace, who derive no value from "education."
If the velocity of lies is ten times faster than truth, humanity may be progressing toward doom. The cause of this phenomena cries out for further research - but then it is unlikely as the social media kings are making money they cannot even count and the academics are still writing papers based on century old ideas to assure tenure.
(1) http://science.sciencemag.org/content/359/6380/1146

Saturday, March 10, 2018

Blue monkeys

As they roll out the next great technology - operating system and all - those behind the "revolution" seem to have missed some basic things. They have reinvented the "blue box," that shows up arbitrarily on your screen - and since they are all engineers, they do not want to give any options to the user. Often on my server, they show a blue box that requires you to "see" the updates and on my desktop, they give me only a few minutes before they forcibly shut my computer down. Monopoly has costs and if the company does not learn it, there could be trouble ahead.
Granted, they may be saving you as they realize the attacks from the East (and perhaps even from the West), but is it worth having a blue box at the center of the screen when you are doing something important or even watching a Netflix movie? More importantly, forcibly rebooting one's computer in the middle of watching a movie, may be taking monopoly power a bit too far. Even if the evil twin from the East is clamoring to get into your computer, throwing up a screen that proclaims your computer has been infected and you should call them so that they can disinfect you, it seems like a high price to pay when you are enjoying a movie. As often the case, engineers do not have much respect for the population and their programs are "most efficient." Efficiency, however, is not the only thing in life.
Makers of operating systems, autonomous cars and search, need to have an introspection. It is unclear if the leaders of these companies, "know everything." The blue box and failed artificial brain are ample evidence that they do not.

Friday, March 9, 2018

Economics 101

As the "best schools," attended by policy makers may have skipped Economics 101, it may be worthwhile to visit basic principles high school graduates understand. Ricardo's comparative advantage holds true in most cases and unilateral tariffs, however "strategic," are value destroying. There are many countries around the world who understood this after many years of bad experimentation. But now, one of the most advanced nations seems to be backtracking. Free trade and free markets are value enhancing for society and if the policy makers have any doubt, they may want to return to high school, perhaps this time avoid the "best ones," and attempt to learn something.
A few people making decisions that determine winners and losers has been shown to be sub optimal. In an integrated world economy, with firms and countries holding comparative advantages in differing competencies and production capabilities, it is always better to create an environment that allows specialization and trade freely. The socialists and worse have had difficulty understanding this concept. Some prescribed how many guns and butter to produce and others misguided by their elite education in the West, strategically imposed tariffs on selected goods and services. Underlying all these bad policies is the assumption that the policy maker has infinite wisdom to optimize. And, that has never worked out.
And now with infinitesimal wisdom, the one who is home alone, is attempting policies that have been conclusively proven to be bad. Education from the "best schools," may not be enough to have sufficient common sense.

Wednesday, February 28, 2018

Less precise health

A recent article (1) proposes that precision health should prioritize actionable information and long-term user engagement. That's a lot of words but it seems to make sense. Hardware and software companies have been on the prowl to sell "precision health," even though they may not know what it means. This could be a shocker for the statisticians, but health is not precise, not by any stretch of the imagination. As they roam the hallways with pocket calculators and actuarial tables, seeking higher and higher "precision," it is important to recognize that the human remains to be the most complex and enigmatic to figure out.
Health is a difficult construct to define. The regulators have gotten wind of "risk," recently and they are clamoring for "risk stratification." None of these people have had any formal education in risk or economics, but they feel they are experts on policy involving the same. They don't even seek information from other industries and that has been symptomatic of the entire healthcare value chain that includes manufacturers, providers, and payers, who seem to know pretty much everything there is to know. Not so. They may be brain surgeons but there are plenty of rocket scientists outside their domains. It may be better to talk to them, before plunging head down into the abyss.
A century of "development," appears to have increased lifespan by 2000 days. But from a utilitarian perspective, the incremental 2000 days gained by fantastic pharmaceuticals, crazy yoga and jumping up and down the whole day, do not seem to add much value. More importantly, the time gained generally reduces the quality of life, impacted by pain, hospitalization, and a lack of flexibility to make decisions. The human brain appears to deteriorate past allowed time and the individual behind the smoke screen suffers. The manufacturers who plunk down close to 100 billion every year into R&D do not seem to have any acceptable answers. The providers, left in the lurch to care for their patients who may not even recognize them, suffer equally. Meanwhile, the accountants at the payers are cranking up their calculators so that they can meet the quarterly EPS.
It is a painful movie to watch. As the brilliant folks in Washington figure out how to save themselves and perhaps the country, there is significant suffering across the landscape. Losing a life is unthinkable, losing a mind is equally traumatic.
(1) http://stm.sciencemag.org/content/10/430/eaao3612

Monday, February 26, 2018

Stop hiring "data scientists."

They have been riding high. The abandoned and somewhat less sexy field of Statistics has taken the business world by storm. Bottling old wine in new bottles certainly helped and now both venture capitalists and operating companies may be heading for a hangover. Engineers and statisticians have always wanted to be scientists and now they are crowned as such. There is a .ai company formed every 15 minutes by graduates of prestigious universities and there are capitalists with sacks of money willing to entertain them. As we have seen before, this movie will likely end in tears for many.
Data is certainly a good thing and applying "science," to it could also be good. But those who assert their "scientific credentials," based on regressions and neural nets should be aware that the slide rules they are using have been available for nearly half a century. Mathematics does not fade but asserting old ideas have suddenly sprung to life certainly shows the maturity and age of the emerging "scientists." Consulting firms have always been creative and some of the most famous ones, who could hardly spell "data science," just a few years ago are now pretending to be experts at it. Conferences are plenty where the scientists meet their seekers and the vendors portray their wares almost like the bartering that was routine a few centuries ago. They flow tensors, cognitive networks and even hardware in a Pizza size box, that apparently has solved all the world's problems, already.
Stop hiring "data scientists." They are ordinary human beings with bias and they could do your companies a lot of damage.

Wednesday, February 7, 2018

Breathe, breathe in the air

As the first biological entities emerged out of the water and into the land, the battle was just beginning. The toxic air was oxygenated over time and as complexity increased, they had to develop sophisticated systems to breathe. The toxin turned into life-giving Oxygen and over a million years, humanoids experimented with systems that could shuttle the magic molecule to power their systems.
Allergies and asthma followed modern humans as they transversed the globe with their badly designed respiratory systems, prone to catastrophic failure and that killed them in large numbers. Later, modern medicine will keep them alive for a few more decades but they often succumb to the inability to oxygenate. Their nemesis, the Virus, attacked their Achilles heel as most died of the common cold and some of the more advanced versions, aptly named Pneumonia. Recent news (1) that claims advances in bronchodilator drugs in asthma is certainly welcome news.
Humans, fragile and badly designed in most systems, do not appear to be robust enough to move to the next stage.
(1) http://stm.sciencemag.org/content/10/427/eaam8604

Monday, January 22, 2018

Personalized medicine

It appears that the completely archaic notion of mass-produced drugs for the average patient is about to change (1). The manufacturers paid lip service to personalized medicine for nearly a century and it was clear that their heart or business models were never in it. The normal function may have done as much damage to humanity as nuclear weapons, for those who adhere to it blindly believe in averages and standard deviations based on a manufactured construct. The only redeeming quality of humans is that they are different and diverse. As the men in power separate the weak from the wealthy, the struggling from those who never struggled, the golfers from those who cannot afford a club, the academics from practitioners, the atheists from the religious, the North from the South, the West from the East, they miss an important point - every human on Earth is different, regardless of the visible features they exhibit or where they originate from.
The design of clinical trials seems to fail this basic notion. Pushing humans through protocols like cattle through a food manufacturing company is not the best way to discover drugs. It is certainly the best way to reduce costs and to prove to the regulators that something important has been done. In the process, they left large underserved populations in the lurch and pumped those who take the medicine with a dose that is suboptimal. Emerging technologies are immensely capable to figure out who will benefit from a drug and who will not and at what quantity. It is time statisticians left the industry as their contributions do more harm than good, not unlike the insurance industry, clinging to actuarial tables.
Now, available technology can titrate every individual to the optimal dose and we do not need, "population statistics," to approve or to disapprove drugs. If the regulators do not return to school to learn what has been happening, they will continue to make bad decisions.
(1) Digitization of multistep organic synthesis in reactionware for on-demand pharmaceuticals
Philip J. Kitson, Guillaume Marie, Jean-Patrick Francoia, Sergey S. Zalesskiy, Ralph C. Sigerson, Jennifer S. Mathieson, Leroy Cronin*

Saturday, January 20, 2018

The dawn of non-invasive diagnostics

Recent news that a single blood test could provide the diagnosis of eight common cancers with 99% specificity (1) is a constant reminder that medicine is still stuck in archaic and invasive procedures to detect, diagnose and treat ailments. With a high concentration of human resources in provider settings, medicine has been slow in embracing emerging technologies and ideas, outside the domain. And this attitude is shared across the healthcare value chain including manufacturers, payers, and regulators.
It is unfortunate. Granted, Biology still remains to be the arena where humans could not progress exponentially. Their brains, with millions of years of deterministic training, have been well specialized to dominate engineering and chemistry. However, they could not understand the marvelous machines assembled by nature from a single cell organism to somewhat more complex humans, with any level of precision. Nature has had time to perfect designs of such beauty and humans, ever curious, have been trying to walk up to the cup of knowledge. But it has not been. Fossils indicate attempts at brain surgery many hundreds of thousands of years ago and despite higher structural knowledge, we have not advanced sufficiently to a differentiable plateau. In most simpler fields, we have demonstrably shown that humans are the weak links in decision processes - from transportation, energy, manufacturing and even, finance.
It is a conundrum. We are stuck - great strides in deterministic sciences do not translate into domains of high uncertainty and diversity. And, those who practice in these complex domains seem to have their blindfolds on as if they have nothing more to learn.  Diagnostics could provide the impetus to move higher - serum and stool harbor such information content, it is a shame we have not figured it out.
(1) Detection and localization of surgically resectable cancers with a multi-analyte blood test
1.        Joshua D. Cohen1,2,3,4,5, Lu Li6, Yuxuan Wang1,2,3,4, Christopher Thoburn3, Bahman Afsari7, Ludmila Danilova7, Christopher Douville1,2,3,4, Ammar A. Javed8, Fay Wong1,2,3,4, Austin Mattox1,2,3,4, Ralph. H. Hruban3,4,9, Christopher L. Wolfgang8, Michael G. Goggins3,4,9,10,11, Marco Dal Molin4, Tian-Li Wang3,9, Richard Roden3,9, Alison P. Klein3,4,12, Janine Ptak1,2,3,4, Lisa Dobbyn1,2,3,4, Joy Schaefer1,2,3,4, Natalie Silliman1,2,3,4, Maria Popoli1,2,3,4, Joshua T. Vogelstein13, James D. Browne14, Robert E. Schoen15,16, Randall E. Brand15, Jeanne Tie17,18,19,20, Peter Gibbs17,18,19,20, Hui-Li Wong17, Aaron S. Mansfield21, Jin Jen22, Samir M. Hanash23, Massimo Falconi24, Peter J. Allen25, Shibin Zhou1,3,4, Chetan Bettegowda1,2,3,4, Luis Diaz1,3,4, Cristian Tomasetti3,6,7,*, Kenneth W. Kinzler1,3,4,*, Bert Vogelstein1,2,3,4,*, Anne Marie Lennon3,4,8,10,11,*, Nickolas Papadopoulos1,3,4,*